Home › Research › Laboratory science
Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy
Browne DF, Smirnov DS, Coughlin DG, Peng I, Standke HG, Kim Y, Pizzo DP, Unapanta A, Andreasson T, Hiniker A, Kraus A. Nature Communications, 2025-02-21
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Tau neurofibrillary tangles (NFTs) in the presence of amyloid-β (Aβ) plaques are required for the diagnosis of Alzheimer's Disease (AD) and closely track with cognitive impairment, yet cognitively normal aged individuals frequently exhibit NFTs arising from tau seed accumulation. This may suggest that not all tau species are equally pathogenic and raises the question of whether unidentified tau modifications augment tau seeding activity and neurodegeneration in AD. We investigated how biochemical modifications of tau relate to clinicopathological outcomes in a cohort of 38 patients with Braak-matched AD neuropathologic change (ADNC) or primary age-related tauopathy (PART), a 3R/4R tauopathy with identical tau filament core structure to ADNC but with little to no Aβ deposition. We comprehensively measured tau histologic density, seeding activity using real-time quaking induced conversion (RT-QuIC) seed amplification assays, and select post-translational modifications (PTMs) (i.e. pT217, pS202/T205, & C-terminal epitopes) in hippocampus and neocortex. Even in cases without overt neocortical tau neuropathology, substantial hippocampal and neocortical tau seeding occurred in both PART and ADNC and predicted region-specific cognitive performance and longitudinal decline. Notably, tau seeding and PTM profiles were associated with Aβ neuritic plaque density and differentiated ADNC from PART in neocortex. Our data indicate that tau seed modifications meaningfully relate to disease trajectory, potentially explaining the more severe cognitive dysfunction observed in late-stage AD versus PART.
What this study adds
Evidence grade: Early
This is a case-control study of 38 participants. In 38 patients with Braak-matched Alzheimer's disease neuropathologic change or primary age-related tauopathy, tau seeding and post-translational modification profiles were associated with amyloid-beta neuritic plaque density and differentiated the two conditions in neocortex. Its stated limit: Both PART and ADNC show asymmetric neuropathology, especially early, and the standard brain-bank practice of fixing one hemisphere and freezing the other is a known limitation that may attenuate the strength of associations.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Browne, D. F., Smirnov, D. S., Coughlin, D. G., Peng, I., Standke, H. G., Kim, Y., et al. (2025). Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy. Nature Communications. https://doi.org/10.1038/s41467-025-56469-7
Vancouver
Browne DF, Smirnov DS, Coughlin DG, Peng I, Standke HG, Kim Y, et al. Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy. Nature Communications. 2025. doi:10.1038/s41467-025-56469-7. PMID: 39984462.
BibTeX
@article{browne2025-39984462,
author = {Browne, D. F. and Smirnov, D. S. and Coughlin, D. G. and Peng, I. and Standke, H. G. and Kim, Y. and Pizzo, D. P. and Unapanta, A. and Andreasson, T. and Hiniker, A. and Kraus, A.},
title = {{Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy}},
journal = {Nature Communications},
year = {2025},
doi = {10.1038/s41467-025-56469-7},
pmid = {39984462},
url = {https://doi.org/10.1038/s41467-025-56469-7}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 11 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- This may suggest that not all tau species are equally pathogenic and raises the question of whether unidentified tau modifications augment tau seeding activity and neurodegeneration in AD.
- Notably, tau seeding and PTM profiles were associated with Aβ neuritic plaque density and differentiated ADNC from PART in neocortex.
- Our data indicate that tau seed modifications meaningfully relate to disease trajectory, potentially explaining the more severe cognitive dysfunction observed in late-stage AD versus PART.
Why it matters
In 38 patients with Braak-matched Alzheimer's disease neuropathologic change or primary age-related tauopathy, tau seeding and post-translational modification profiles were associated with amyloid-beta neuritic plaque density and differentiated the two conditions in neocortex. The data suggest tau seed modifications relate to disease trajectory and may explain more severe cognitive dysfunction in late-stage Alzheimer's disease, but no treatment is tested.
Study details
- Study designcase-control
- Participants38
- Evidence strengthEarly
Limitations
Both PART and ADNC show asymmetric neuropathology, especially early, and the standard brain-bank practice of fixing one hemisphere and freezing the other is a known limitation that may attenuate the strength of associations.
How this study scored 61/100
Published in a leading specialty journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 60 of the 98 points we could judge it on, which is 61 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Nature Communications) |
| Journal's citation record | 4 / 4 | Nature Communications: journal h-index 747 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 2 / 5 | Rated “early” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 38 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 15 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 8.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Allison Kraus: h-index 25 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39984462) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 60 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 60 of the 98 points we could judge it on is 61 out of 100. |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Laboratory science from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.